SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    John A. Christopher, Jason Brown, Andrew S. Doré, James C. Errey, Markus Koglin, Fiona H. Marshall, David G. Myszka, Rebecca L. Rich, Christopher G. Tate, Benjamin Tehan, Tony Warne, Miles Congreve, Biophysical Fragment Screening of the β1-Adrenergic Receptor: Identification of High Affinity Arylpiperazine Leads Using Structure-Based Drug Design, Journal of Medicinal Chemistry, 2013, 56, 9, 3446

    CrossRef

  2. 2
    Dennis Ladage, Robert H.G. Schwinger, Klara Brixius, Cardio-Selective Beta-Blocker: Pharmacological Evidence and Their Influence on Exercise Capacity, Cardiovascular Therapeutics, 2013, 31, 2
  3. 3
    N Flacco, V Segura, M Perez-Aso, S Estrada, JF Seller, F Jiménez-Altayó, MA Noguera, P D'Ocon, E Vila, MD Ivorra, Different β-adrenoceptor subtypes coupling to cAMP or NO/cGMP pathways: implications in the relaxant response of rat conductance and resistance vessels, British Journal of Pharmacology, 2013, 169, 2
  4. 4
    Michitsugu Arai, Takuma Sato, Shoko Takeuchi, Shigemi Goto, Akifumi Togari, Dose effects of butoxamine, a selective β2-adrenoceptor antagonist, on bone metabolism in spontaneously hypertensive rat, European Journal of Pharmacology, 2013, 701, 1-3, 7

    CrossRef

  5. 5
    Ching-I. Anderson Wang, Richard J. Lewis, Emerging opportunities for allosteric modulation of G-protein coupled receptors, Biochemical Pharmacology, 2013, 85, 2, 153

    CrossRef

  6. 6
    H. M. Wang, Z. X. Liao, R. Komaki, J. W. Welsh, M. S. O'Reilly, J. Y. Chang, Y. Zhuang, L. B. Levy, C. Lu, D. R. Gomez, Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy, Annals of Oncology, 2013, 24, 5, 1312

    CrossRef

  7. 7
    Joaquín Pérez-Schindler, Andrew Philp, Jesús Hernandez-Cascales, Pathophysiological relevance of the cardiac β2-adrenergic receptor and its potential as a therapeutic target to improve cardiac function, European Journal of Pharmacology, 2013, 698, 1-3, 39

    CrossRef

  8. 8
    Edip G. Cekic, Guray Soydan, Sebile Guler, Melih O. Babaoglu, Meral Tuncer, Propranolol-induced relaxation in the rat basilar artery, Vascular Pharmacology, 2013, 58, 4, 307

    CrossRef

  9. 9
    Yuri Aono, Tadashi Saigusa, Hiroko Taguchi, Takuya Uchida, Koji Takada, Noriaki Koshikawa, Alexander R. Cools, Synergistic, but not separate, stimulation of accumbal β1- and β2-adrenoceptors alters the accumbal dopamine efflux in freely moving rats, European Journal of Pharmacology, 2013,

    CrossRef

  10. 10
    Shailesh N. Mistry, Jillian G Baker, Peter M Fischer, Stephen J Hill, Sheila M Gardiner, Barrie Kellam, Synthesis and in Vitro and in Vivo Characterization of Highly β1-Selective β-Adrenoceptor Partial Agonists, Journal of Medicinal Chemistry, 2013, 130510162633002

    CrossRef

  11. 11
    Adrian Gericke, Tobias Böhmer, Martin C. Michel, β3-Adrenoceptors: a drug target in ophthalmology?, Naunyn-Schmiedeberg's Archives of Pharmacology, 2013, 386, 4, 265

    CrossRef

  12. 12
    Albert J. Kooistra, Luc Roumen, Rob Leurs, Iwan J.P. de Esch, Chris de Graaf, G Protein Coupled Receptors - Modeling, Activation, Interactions and Virtual Screening, 2013,

    CrossRef

  13. 13
    Maria Cláudia G. Oliveira-Fusaro, Juliana Trindade Clemente-Napimoga, Juliana Maia Teixeira, Karla Elena Torres-Chávez, Carlos Amílcar Parada, Cláudia Herrera Tambeli, 5-HT induces temporomandibular joint nociception in rats through the local release of inflammatory mediators and activation of local β adrenoceptors, Pharmacology Biochemistry and Behavior, 2012, 102, 3, 458

    CrossRef

  14. 14
    J. J. Liu, R. Horst, V. Katritch, R. C. Stevens, K. Wuthrich, Biased Signaling Pathways in  2-Adrenergic Receptor Characterized by 19F-NMR, Science, 2012, 335, 6072, 1106

    CrossRef

  15. 15
    Marvin A. Soriano-Ursúa, Daniel A. McNaught-Flores, Gustavo Nieto-Alamilla, Aldo Segura-Cabrera, José Correa-Basurto, José A. Arias-Montaño, José G. Trujillo-Ferrara, Cell-based and in-silico studies on the high intrinsic activity of two boron-containing salbutamol derivatives at the human β2-adrenoceptor, Bioorganic & Medicinal Chemistry, 2012, 20, 2, 933

    CrossRef

  16. 16
    Rui Lin, Simone Degan, Barbara S Theriot, Bernard M Fischer, Ryan T Strachan, Jiurong Liang, Richard A Pierce, Mary E Sunday, Paul W Noble, Monica Kraft, Arnold R Brody, Julia KL Walker, Chronic treatment in vivo with β-adrenoceptor agonists induces dysfunction of airway β2-adrenoceptors and exacerbates lung inflammation in mice, British Journal of Pharmacology, 2012, 165, 7
  17. 17
    Balaji Selvam, Jeff Wereszczynski, Irina G. Tikhonova, Comparison of Dynamics of Extracellular Accesses to the β1 and β2 Adrenoceptors Binding Sites Uncovers the Potential of Kinetic Basis of Antagonist Selectivity, Chemical Biology & Drug Design, 2012, 80, 2
  18. 18
    Philip M. Short, Peter A. Williamson, Brian J. Lipworth, Effects of hydrocortisone on acute β-adrenoceptor blocker and histamine induced bronchoconstriction, British Journal of Clinical Pharmacology, 2012, 73, 5
  19. 19
    Yutaka Kofuku, Takumi Ueda, Junya Okude, Yutaro Shiraishi, Keita Kondo, Masahiro Maeda, Hideki Tsujishita, Ichio Shimada, Efficacy of the β2-adrenergic receptor is determined by conformational equilibrium in the transmembrane region, Nature Communications, 2012, 3, 1045

    CrossRef

  20. 20
    Yasuhiko Igawa, Tim Schneider, Yoshinobu Yamazaki, Satoshi Tatemichi, Yukio Homma, Osamu Nishizawa, Martin C. Michel, Functional investigation of β-adrenoceptors in human isolated detrusor focusing on the novel selective β3-adrenoceptor agonist KUC-7322, Naunyn-Schmiedeberg's Archives of Pharmacology, 2012, 385, 8, 759

    CrossRef

  21. 21
    Sebastian Majewski, Sebastian Slomka, Ewa Zielinska-Wyderkiewicz, Maciej Ciebiada, Pawel Gorski, Heart Rate-Lowering Efficacy and Respiratory Safety of Ivabradine in Patients with Obstructive Airway Disease, American Journal Cardiovascular Drugs, 2012, 12, 3, 179

    CrossRef

  22. 22
    Yuki Takeda, Yoshiaki Yano, Katsumi Matsuzaki, High-Throughput Analysis of Ligand-Induced Internalization of β2-Adrenoceptors Using the Coiled-Coil Tag–Probe Method, Analytical Chemistry, 2012, 84, 3, 1754

    CrossRef

  23. 23
    Yasuhiro Takayanagi, Satoshi Osawa, Mutsuhiro Ikuma, Kosuke Takagaki, Jiong Zhang, Yasushi Hamaya, Takanori Yamada, Mitsushige Sugimoto, Takahisa Furuta, Hiroaki Miyajima, Ken Sugimoto, Norepinephrine suppresses IFN-γ and TNF-α production by murine intestinal intraepithelial lymphocytes via the β1 adrenoceptor, Journal of Neuroimmunology, 2012, 245, 1-2, 66

    CrossRef

  24. 24
    Ahmad Reza Bekhradnia, Mohammad Ali Ebrahimzadeh, Theoretical study on some non-selective beta-adrenergic antagonists and correlation to their biologically active configurations, Medicinal Chemistry Research, 2012, 21, 9, 2571

    CrossRef

  25. 25
    Felipe Carvalho de Oliveira, Gilson Soares Feitosa-Filho, Luiz Eduardo Fonteles Ritt, Use of beta-blockers for the treatment of cardiac arrest due to ventricular fibrillation/pulseless ventricular tachycardia: A systematic review, Resuscitation, 2012, 83, 6, 674

    CrossRef

  26. 26
    Jennifer M Wright, May R S Dobosiewicz, Paul B S Clarke, α- and β-Adrenergic Receptors Differentially Modulate the Emission of Spontaneous and Amphetamine-Induced 50-kHz Ultrasonic Vocalizations in Adult Rats, Neuropsychopharmacology, 2012, 37, 3, 808

    CrossRef

  27. 27
    Vincenzo De Giorgi, Marta Grazzini, Sara Gandini, Silvia Benemei, Curtis D Asbury, Niccolò Marchionni, Pierangelo Geppetti, β-adrenergic-blocking drugs and melanoma: current state of the art, Expert Review of Anticancer Therapy, 2012, 12, 11, 1461

    CrossRef

  28. 28
    Ahmedat S. Ahmedat, Mareille Warnken, Uwe R. Juergens, Michael Paul Pieper, Kurt Racké, β2-adrenoceptors and muscarinic receptors mediate opposing effects on endothelin-1 expression in human lung fibroblasts, European Journal of Pharmacology, 2012, 691, 1-3, 218

    CrossRef

  29. 29
    Makoto R. Hara, Jeffrey J. Kovacs, Erin J. Whalen, Sudarshan Rajagopal, Ryan T. Strachan, Wayne Grant, Aaron J. Towers, Barbara Williams, Christopher M. Lam, Kunhong Xiao, Sudha K. Shenoy, Simon G. Gregory, Seungkirl Ahn, Derek R. Duckett, Robert J. Lefkowitz, A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1, Nature, 2011, 477, 7364, 349

    CrossRef

  30. 30
    Martin C Michel, Sian E Harding, Richard A Bond, Are there functional β3-adrenoceptors in the human heart?, British Journal of Pharmacology, 2011, 162, 4
  31. 31
    Martin C. Michel, Hana Cernecka, Peter Ochodnicky, Desirable properties of β3-adrenoceptor agonists: Implications for the selection of drug development candidates, European Journal of Pharmacology, 2011, 657, 1-3, 1

    CrossRef

  32. 32
    Wei Zhang, Toshishige Shibamoto, Yasutaka Kurata, Hiroyuki Kohno, Effects of β-adrenoceptor antagonists on anaphylactic hypotension in conscious rats, European Journal of Pharmacology, 2011, 650, 1, 303

    CrossRef

  33. 33
    Jillian G. Baker, Stephen J. Hill, Roger J. Summers, Evolution of β-blockers: from anti-anginal drugs to ligand-directed signalling, Trends in Pharmacological Sciences, 2011, 32, 4, 227

    CrossRef

  34. 34
    Florence Verrier, Songon An, Ann M Ferrie, Haiyan Sun, Minjoung Kyoung, Huayun Deng, Ye Fang, Stephen J Benkovic, GPCRs regulate the assembly of a multienzyme complex for purine biosynthesis, Nature Chemical Biology, 2011, 7, 12, 909

    CrossRef

  35. 35
    Marvin A. Soriano-Ursúa, José Correa-Basurto, José G. Trujillo-Ferrara, Alberto J. Kaumann, Homology model and docking studies on porcine β2 adrenoceptor: description of two binding sites, Journal of Molecular Modeling, 2011, 17, 10, 2525

    CrossRef

  36. 36
    Torsten Christ, Peter Molenaar, Paul M Klenowski, Ursula Ravens, Alberto J Kaumann, Human atrial β1L-adrenoceptor but not β3-adrenoceptor activation increases force and Ca2+ current at physiological temperature, British Journal of Pharmacology, 2011, 162, 4
  37. 37
    Graham M. West, Ellen Y.T. Chien, Vsevolod Katritch, Jovylyn Gatchalian, Michael J. Chalmers, Raymond C. Stevens, Patrick R. Griffin, Ligand-Dependent Perturbation of the Conformational Ensemble for the GPCR β2 Adrenergic Receptor Revealed by HDX, Structure, 2011, 19, 10, 1424

    CrossRef

  38. 38
    Wei Zhang, Toshishige Shibamoto, Yuhichi Kuda, Chieko Ohmukai, Yasutaka Kurata, Pulmonary Vasoconstrictive and Bronchoconstrictive Responses to Anaphylaxis Are Weakened via β2-adrenoceptor Activation by Endogenous Epinephrine in Anesthetized Rats, Anesthesiology, 2011, 114, 3, 614

    CrossRef

  39. 39
    Jillian G. Baker, Luke A. Adams, Karolina Salchow, Shailesh N. Mistry, Richard J. Middleton, Stephen J. Hill, Barrie Kellam, Synthesis and Characterization of High-Affinity 4,4-Difluoro-4-bora-3a,4a-diaza-s-indacene-Labeled Fluorescent Ligands for Human β-Adrenoceptors, Journal of Medicinal Chemistry, 2011, 54, 19, 6874

    CrossRef

  40. 40
    J Daniel Hothersall, James Black, Stephen Caddick, Jeremy G Vinter, Andrew Tinker, James R Baker, The design, synthesis and pharmacological characterization of novel β2-adrenoceptor antagonists, British Journal of Pharmacology, 2011, 164, 2
  41. 41
    Ye Fang, The development of label-free cellular assays for drug discovery, Expert Opinion on Drug Discovery, 2011, 6, 12, 1285

    CrossRef

  42. 42
    Hui Peng, Richard A. Bond, Brian J. Knoll, The effects of acute and chronic nadolol treatment on β2AR signaling in HEK293 cells, Naunyn-Schmiedeberg's Archives of Pharmacology, 2011, 383, 2, 209

    CrossRef

  43. 43
    Carmen Gonzalez-Muñoz, Teodomiro Fuente, Santiago Medin-Aguerre, Jesús Hernández-Cascales, The increase in rat ventricular automaticity induced by salbutamol is mediated through β1- but not β2-adrenoceptors: Role of phosphodiesterases, Life Sciences, 2011, 88, 25-26, 1095

    CrossRef

  44. 44
    Jillian G. Baker, Richard G. W. Proudman, Christopher G. Tate, The pharmacological effects of the thermostabilising (m23) mutations and intra and extracellular (β36) deletions essential for crystallisation of the turkey β-adrenoceptor, Naunyn-Schmiedeberg's Archives of Pharmacology, 2011, 384, 1, 71

    CrossRef

  45. 45
    F. Lamyel, M. Warnken-Uhlich, W. K. Seemann, K. Mohr, E. Kostenis, A. S. Ahmedat, M. Smit, R. Gosens, H. Meurs, A. Miller-Larsson, Kurt Racké, The β2-subtype of adrenoceptors mediates inhibition of pro-fibrotic events in human lung fibroblasts, Naunyn-Schmiedeberg's Archives of Pharmacology, 2011, 384, 2, 133

    CrossRef

  46. 46
    Martin C. Michel, Peter Ochodnicky, Yukio Homma, Yasuhiko Igawa, β-Adrenoceptor agonist effects in experimental models of bladder dysfunction, Pharmacology & Therapeutics, 2011, 131, 1, 40

    CrossRef

  47. 47
    Stefan Tasler, Roland Baumgartner, Andrea Aschenbrenner, Astrid Ammendola, Kristina Wolf, Tanja Wieber, Josef Schachtner, Marcus Blisse, Udo Quotschalla, Peter Ney, A vHTS approach for the identification of β-adrenoceptor ligands, Bioorganic & Medicinal Chemistry Letters, 2010, 20, 11, 3399

    CrossRef

  48. 48
    James R. Baker, J. Daniel Hothersall, Richard J. Fitzmaurice, Matthew Tucknott, Andy Vinter, Andrew Tinker, Stephen Caddick, An efficient asymmetric synthesis of the potent β-blocker ICI-118,551 allows the determination of enantiomer dependency on biological activity, Chemical Communications, 2010, 46, 22, 3953

    CrossRef

  49. 49
    V.N. Novoseletsky, T.V. Pyrkov, R.G. Efremov, Analysis of hydrophobic interactions of antagonists with the beta2-adrenergic receptor, SAR and QSAR in Environmental Research, 2010, 21, 1-2, 37

    CrossRef

  50. 50
    An L. Moens, Ronghua Yang, Vabren L. Watts, Lili A. Barouch, Beta 3-adrenoreceptor regulation of nitric oxide in the cardiovascular system, Journal of Molecular and Cellular Cardiology, 2010, 48, 6, 1088

    CrossRef

  51. You have free access to this content51
    C. L. Chang, G. D. Mills, J. D. McLachlan, N. C. Karalus, R. J. Hancox, Cardio-selective and non-selective beta-blockers in chronic obstructive pulmonary disease: effects on bronchodilator response and exercise, Internal Medicine Journal, 2010, 40, 3
  52. 52
    P. Senthil Kumar, Prasad V. Bharatam, Comparative 3D QSAR study on β1-, β2-, and β3-adrenoceptor agonists, Medicinal Chemistry Research, 2010, 19, 9, 1121

    CrossRef

  53. 53
    Marvin A. Soriano-Ursúa, José G. Trujillo-Ferrara, Jesús Álvarez-Cedillo, José Correa-Basurto, Docking studies on a refined human β2 adrenoceptor model yield theoretical affinity values in function with experimental values for R-ligands, but not for S-antagonists, Journal of Molecular Modeling, 2010, 16, 3, 401

    CrossRef

  54. 54
    T.-J. Zhao, I. Sakata, R. L. Li, G. Liang, J. A. Richardson, M. S. Brown, J. L. Goldstein, J. M. Zigman, From the Cover: Ghrelin secretion stimulated by  1-adrenergic receptors in cultured ghrelinoma cells and in fasted mice, Proceedings of the National Academy of Sciences, 2010, 107, 36, 15868

    CrossRef

  55. 55
    Alejandro Galindo-Tovar, Maria Luisa Vargas, Alberto J. Kaumann, Function of cardiac β1- and β2-adrenoceptors of newborn piglets: Role of phosphodiesterases PDE3 and PDE4, European Journal of Pharmacology, 2010, 638, 1-3, 99

    CrossRef

  56. 56
    Yuval Silberman, Olusegun J Ariwodola, Ann M Chappell, Jordan T Yorgason, Jeff L Weiner, Lateral Paracapsular GABAergic Synapses in the Basolateral Amygdala Contribute to the Anxiolytic Effects of β3 Adrenoceptor Activation, Neuropsychopharmacology, 2010, 35, 9, 1886

    CrossRef

  57. 57
    Michael P. Bokoch, Yaozhong Zou, Søren G. F. Rasmussen, Corey W. Liu, Rie Nygaard, Daniel M. Rosenbaum, Juan José Fung, Hee-Jung Choi, Foon Sun Thian, Tong Sun Kobilka, Joseph D. Puglisi, William I. Weis, Leonardo Pardo, R. Scott Prosser, Luciano Mueller, Brian K. Kobilka, Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor, Nature, 2010, 463, 7277, 108

    CrossRef

  58. You have free access to this content58
    Anthony Ivetac, J. Andrew McCammon, Mapping the Druggable Allosteric Space of G-Protein Coupled Receptors: a Fragment-Based Molecular Dynamics Approach, Chemical Biology & Drug Design, 2010, 76, 3
  59. 59
    Jillian G Baker, The selectivity of β-adrenoceptor agonists at human β1-, β2- and β3-adrenoceptors, British Journal of Pharmacology, 2010, 160, 5
  60. 60
    Vsevolod Katritch, Kimberly A. Reynolds, Vadim Cherezov, Michael A. Hanson, Christopher B. Roth, Mark Yeager, Ruben Abagyan, Analysis of full and partial agonists binding to β2-adrenergic receptor suggests a role of transmembrane helix V in agonist-specific conformational changes, Journal of Molecular Recognition, 2009, 22, 4
  61. 61
    Tenille E. Ragoonanan, W Scott Beattie, C David Mazer, Albert K.Y. Tsui, Howard Leong-Poi, David F. Wilson, Gordon Tait, Julie Yu, Elaine Liu, Melissa Noronha, Neil D. Dattani, Nicholas Mitsakakis, Gregory M. T. Hare, Metoprolol Reduces Cerebral Tissue Oxygen Tension after Acute Hemodilution in Rats, Anesthesiology, 2009, 111, 5, 988

    CrossRef

  62. 62
    Gaspare Parrinello, Salvatore Paterna, Daniele Torres, Pietro Di Pasquale, Manuela Mezzero, Gabriella La Rocca, Mauro Cardillo, Caterina Trapanese, Mario Caradonna, Giuseppe Licata, One-Year Renal and Cardiac Effects of Bisoprolol versus Losartan in Recently Diagnosed Hypertensive Patients, Clinical Drug Investigation, 2009, 29, 9, 591

    CrossRef

  63. 63
    Takahiro Horinouchi, Shigeru Morishima, Yoshio Tanaka, Katsuo Koike, Soichi Miwa, Ikunobu Muramatsu, Pharmacological evaluation of ocular β-adrenoceptors in rabbit by tissue segment binding method, Life Sciences, 2009, 84, 5-6, 181

    CrossRef

  64. 64
    C. Gonzalez-Muñoz, Teodomiro Fuente, J. Hernández-Cascales, Phosphodiesterases inhibition unmask a positive inotropic effect mediated by β2-adrenoceptors in rat ventricular myocardium, European Journal of Pharmacology, 2009, 607, 1-3, 151

    CrossRef

  65. 65
    Daniel M. Rosenbaum, Søren G. F. Rasmussen, Brian K. Kobilka, The structure and function of G-protein-coupled receptors, Nature, 2009, 459, 7245, 356

    CrossRef

  66. 66
    Brian J. Lipworth, Peter A. Williamson, Think the impossible: β-blockers for treating asthma, Clinical Science, 2009, 118, 2, 115

    CrossRef

  67. 67
    Rui Lin, Hui Peng, Long P. Nguyen, Noor B. Dudekula, Felix Shardonofsky, Brian J. Knoll, Sergio Parra, Richard A. Bond, Changes in β2-adrenoceptor and other signaling proteins produced by chronic administration of ‘β-blockers’ in a murine asthma model, Pulmonary Pharmacology & Therapeutics, 2008, 21, 1, 115

    CrossRef

  68. 68
    Maura Floreani, Katia Varani, Luigi Quintieri, Pier Andrea Borea, Paola Dorigo, Comparison of the binding affinity of CGP-12177A at recombinant rat α1D-adrenoceptors expressed in BHK-21 cell membranes and α1-adrenoceptors present in rat cerebral cortex membranes, European Journal of Pharmacology, 2008, 590, 1-3, 303

    CrossRef

  69. 69
    Louis J. Ignarro, Different Pharmacological Properties of Two Enantiomers in a Unique β-Blocker, Nebivolol, Cardiovascular Therapeutics, 2008, 26, 2
  70. 70
    Bradford S. Hamilton, Henri N. Doods, Identification of potent agonists acting at an endogenous atypical β3-adrenoceptor state that modulate lipolysis in rodent fat cells, European Journal of Pharmacology, 2008, 580, 1-2, 55

    CrossRef

  71. 71
    N. Bonnet, C.L. Benhamou, L. Malaval, C. Goncalves, L. Vico, V. Eder, C. Pichon, D. Courteix, Low dose beta-blocker prevents ovariectomy-induced bone loss in rats without affecting heart functions, Journal of Cellular Physiology, 2008, 217, 3
  72. 72
    Andreas Rickenbacher, Roland Seiler, Ulrich Honegger, Sidney G. Shaw, Bruno M. Balsiger, Role of β1-, β2-, and β3-adrenoceptors in contractile hypersensitivity in a model of small bowel transplantation, Surgery, 2008, 143, 1, 94

    CrossRef

  73. 73
    Elfaridah P. Frazier, Stephan L. M. Peters, Alan S. Braverman, Michael R. Ruggieri, Martin C. Michel, Signal transduction underlying the control of urinary bladder smooth muscle tone by muscarinic receptors and β-adrenoceptors, Naunyn-Schmiedeberg's Archives of Pharmacology, 2008, 377, 4-6, 449

    CrossRef

  74. 74
    Tony Warne, Maria J. Serrano-Vega, Jillian G. Baker, Rouslan Moukhametzianov, Patricia C. Edwards, Richard Henderson, Andrew G. W. Leslie, Christopher G. Tate, Gebhard F. X. Schertler, Structure of a β1-adrenergic G-protein-coupled receptor, Nature, 2008, 454, 7203, 486

    CrossRef

  75. 75
    Alberto J. Kaumann, Peter Molenaar, The low-affinity site of the β1-adrenoceptor and its relevance to cardiovascular pharmacology, Pharmacology & Therapeutics, 2008, 118, 3, 303

    CrossRef

  76. 76
    Michael Sabio, Kenneth Jones, Sid Topiol, Use of the X-ray structure of the β2-adrenergic receptor for drug discovery. Part 2: Identification of active compounds, Bioorganic & Medicinal Chemistry Letters, 2008, 18, 20, 5391

    CrossRef

  77. 77
    Ji-Hui Zhao, Ji-Hua Fu, Shu-Ming Wang, Chang-Hai Su, Ying Shan, Shu-Jia Kong, Yuan Wang, Wan-Liang Lu, Hua Zhang, Shuang Zhang, Lin Li, En-Hong Zhang, Li Wang, Qiu-Ling Pei, Jian-Cheng Wang, Xuan Zhang, Qiang Zhang, A novel transdermal patch incorporating isosorbide dinitrate with bisoprolol: In vitro and in vivo characterization, International Journal of Pharmaceutics, 2007, 337, 1-2, 88

    CrossRef

  78. 78
    Thierry H. Le Jemtel, Margherita Padeletti, Sanja Jelic, Diagnostic and Therapeutic Challenges in Patients With Coexistent Chronic Obstructive Pulmonary Disease and Chronic Heart Failure, Journal of the American College of Cardiology, 2007, 49, 2, 171

    CrossRef

  79. 79
    Ai Ling Fu, Xue Bin Yan, Li Sui, Down-regulation of β1-adrenoceptors gene expression by short interfering RNA impairs the memory retrieval in the basolateral amygdala of rats, Neuroscience Letters, 2007, 428, 2-3, 77

    CrossRef

  80. 80
    V Maupoil, C Bronquard, J-L Freslon, P Cosnay, I Findlay, Ectopic activity in the rat pulmonary vein can arise from simultaneous activation of α1- and β1-adrenoceptors, British Journal of Pharmacology, 2007, 150, 7
  81. 81
    Richard A. Bond, Domenico Spina, Sergio Parra, Clive P. Page, Getting to the heart of asthma: Can “β blockers” be useful to treat asthma?, Pharmacology & Therapeutics, 2007, 115, 3, 360

    CrossRef

  82. 82
    Robert G. Townley, Interleukin 13 and the β-adrenergic blockade theory of asthma revisited 40 years later, Annals of Allergy, Asthma & Immunology, 2007, 99, 3, 215

    CrossRef

  83. 83
    Salvatore Paterna, Gaspare Parrinello, Pietro Pasquale, Daniele Torres, Gabriella Rocca, Roberta Antona, Laura Vernuccio, Ersilia Fornaciari, Antonina Tarantino, Ercole Piccione, Sergio Fasullo, Giuseppe Licata, Medium-term effects of bisoprolol administration on renal hemodynamics and function in mild to moderate essential hypertension, Advances in Therapy, 2007, 24, 6, 1260

    CrossRef

  84. 84
    Jillian G. Baker, Stephen J. Hill, Multiple GPCR conformations and signalling pathways: implications for antagonist affinity estimates, Trends in Pharmacological Sciences, 2007, 28, 8, 374

    CrossRef

  85. 85
    Angela K. Clouse, Erin Riedel, J. Paul Hieble, Timothy D. Westfall, The effects and selectivity of β-adrenoceptor agonists in rat myometrium and urinary bladder, European Journal of Pharmacology, 2007, 573, 1-3, 184

    CrossRef

  86. 86
    B Grotthus, T Piasecki, M Pieśniewska, P Marszalik, J Kwiatkowska, M Skrzypiec-Spring, A Szelag, The Influence of prolonged β-blockers treatment on male rabbit's sexual behavior and penile microcirculation, International Journal of Impotence Research, 2007, 19, 1, 49

    CrossRef

  87. 87
    Wim Vrydag, Martin C. Michel, Tools to study β3-adrenoceptors, Naunyn-Schmiedeberg's Archives of Pharmacology, 2007, 374, 5-6, 385

    CrossRef

  88. 88
    Ian A Yang, Taria Ng, Peter Molenaar, Kwun M Fong, β2-ADRENOCEPTOR POLYMORPHISMS AND OBSTRUCTIVE AIRWAY DISEASES: IMPORTANT ISSUES OF STUDY DESIGN, Clinical and Experimental Pharmacology and Physiology, 2007, 34, 10
  89. 89
    Dana S. Hutchinson, Ekaterina Chernogubova, Masaaki Sato, Roger J. Summers, Tore Bengtsson, Agonist effects of zinterol at the mouse and human β3-adrenoceptor, Naunyn-Schmiedeberg's Archives of Pharmacology, 2006, 373, 2, 158

    CrossRef

  90. 90
    Peter Molenaar, Lu Chen, William A Parsonage, Cardiac implications for the use of β2-adrenoceptor agonists for the management of muscle wasting, British Journal of Pharmacology, 2006, 147, 6
  91. 91
    Wendy W Batenburg, Joep HM van Esch, Ingrid M Garrelds, Ulrich Jorde, Jos MJ Lamers, Dick HW Dekkers, Thomas Walther, Elaine Kellett, Graeme Milligan, Jorge P van Kats, AH Jan Danser, Carvedilol-induced antagonism of angiotensin II: a matter of α1-adrenoceptor blockade, Journal of Hypertension, 2006, 24, 7, 1355

    CrossRef

  92. 92
    Nadja Niclauß, Martina B. Michel-Reher, Astrid E. Alewijnse, Martin C. Michel, Comparison of three radioligands for the labelling of human β-adrenoceptor subtypes, Naunyn-Schmiedeberg's Archives of Pharmacology, 2006, 374, 2, 99

    CrossRef

  93. 93
    Elfaridah P. Frazier, Tim Schneider, Martin C. Michel, Effects of gender, age and hypertension on β-adrenergic receptor function in rat urinary bladder, Naunyn-Schmiedeberg's Archives of Pharmacology, 2006, 373, 4, 300

    CrossRef

  94. 94
    Christian Pott, Dirk Steinritz, Andreas Napp, Wilhelm Bloch, Robert H.G. Schwinger, Klara Brixius, Zur Funktion des β3-Adrenozeptors am Herzen: Signaltransduktion, inotroper Effekt und therapeutischer Ausblick, Wiener Medizinische Wochenschrift, 2006, 156, 15-16, 451

    CrossRef

  95. 95
    Martin C. Michel, Wim Vrydag, α1-, α2- and β-adrenoceptors in the urinary bladder, urethra and prostate, British Journal of Pharmacology, 2006, 147, S2
  96. 96
    T. Meinertz, T. Eschenhagen, β-Rezeptorenblocker bei kardiovaskulären Erkrankungen, Clinical Research in Cardiology Supplements, 2006, 1, 1, 43

    CrossRef

  97. 97
    K T Murphy, H Bundgaard, T Clausen, β3-Adrenoceptor agonist stimulation of the Na+,K+-pump in rat skeletal muscle is mediated by β2- rather than β3-adrenoceptors, British Journal of Pharmacology, 2006, 149, 6
  98. 98
    Ana M Briones, Craig J Daly, Francesc Jimenez-Altayo, Sonia Martinez-Revelles, Jose M Gonzalez, John C McGrath, Elisabet Vila, Direct demonstration of β1- and evidence against β2- and β3-adrenoceptors, in smooth muscle cells of rat small mesenteric arteries, British Journal of Pharmacology, 2005, 146, 5
  99. 99
    Ming Zheng, Weizhong Zhu, Qide Han, Rui-Ping Xiao, Emerging concepts and therapeutic implications of β-adrenergic receptor subtype signaling, Pharmacology & Therapeutics, 2005, 108, 3, 257

    CrossRef

  100. 100
    Joanna Owens, G-protein-coupled receptors: Better beta-blockers, Nature Reviews Drug Discovery, 2005, 4, 5, 371

    CrossRef

  101. 101
    Fabrice Pourageaud, Véronique Leblais, Nadège Bellance, Roger Marthan, Bernard Muller, Role of β2-adrenoceptors (ß-AR), but not ß1-, β3-AR and endothelial nitric oxide, in β-AR-mediated relaxation of rat intrapulmonary artery, Naunyn-Schmiedeberg's Archives of Pharmacology, 2005, 372, 1, 14

    CrossRef